11 research outputs found
Recommended from our members
Investigating the lowest threshold of vascular benefits from LDL cholesterol lowering with a PCSK9 mAb inhibitor (alirocumab) in healthy volunteers - a mechanistic physiological study (INTENSITY-LOW): protocol and study rationale.
Objective: Whether reducing low density lipoprotein cholesterol (LDL-C) is associated with cardiovascular benefits in low risk normocholesterolaemic subjects is unknown. The INTENSITY LOW [Investigating the lowest threshold of vascular benefits from LDL-cholesterol lowering with a PCSK9 mAb inhibitor (alirocumab) in healthy volunteers] study aims to assess whether lowering LDL-C by alirocumab monotherapy can improve endothelial-dependent vascular function compared with placebo (primary objective) in low-risk normocholesterolaemic healthy individuals. Changes in endothelial-dependent or endothelial-independent vascular function, arterial stiffness and biomarkers of systemic inflammation by alirocumab, atorvastatin or their combination are secondary objectives. Study design and methods: This is a single-center, randomized, two-period, single-blind, placebo-controlled clinical trial. The study was registered on clinicaltrials.gov (N03273972). It will include 30 healthy low-risk subjects with LDL-Câ<â4.1âmmol/l. After passing the screening visit (Visit 1), eligible participants will be randomized 1:1 to either subcutaneous alirocumab 150âmg or placebo. These will be administered as single doses in 2 visits 14âdays apart (Visits 2 and 3). Atorvastatin 20âmg once nightly will be prescribed for 14âdays at Visit 3 in both groups through to Visit 4. At baseline (Visit 2) and during all post-dose visits (Visits 3-4), endothelial function will be assessed using venous occlusion plethysmography. Specifically, changes in forearm blood flow responses to intra-arterial infusions of acetylcholine, sodium nitroprusside and L-NG-monomethyl-arginine acetate will be assessed as surrogates of endothelial-dependent and -independent vasodilatation. Additionally, arterial stiffness and carotid intima-media thickness will be evaluated at the same timepoints. The above-mentioned changes will be correlated with changes in lipid and systemic inflammation biomarkers
A COMPARISON OF THE EFFECTS OF VARIOUS LEARNING PROCEDURES UPON PUNCTUATION AND CONTENT IN A FREE WRITING SITUATION
Integrative Health Thematic Strategy Increases Learning Outcomes And Students âClean And Healthy Living Behaviors
Evolutionary factors in design preferences
There is a large body of research documenting sex differences in certain visual-spatial skills, and relating these differences to evolutionary factors. There is also a growing body of work documenting sex differences in design preferences. This article seeks to bring these bodies of work together, presenting a model suggesting that sex differences in visual-spatial abilities may have worked alongside evolutionary pressures to encourage the sex differences observed in design preferences. It will also seek to identify areas in our knowledge where there are gaps, and, from these, suggest areas for further research. It will begin by reviewing the literature on sex differences in visual-spatial abilities, and then consider the literature concerning sex differences in design productions and preferences. From there, it will address possible evolutionary explanations and attempt to tie these different strands of research together